References
- Domsch KH, Gams W, Anderson TH. Compendium of Soil Fungi. London: Academic Press, 1980; 509–510.
- Ben Hamida F, Achard JM, Westeel PF, et al. Leg granuloma due to Neocosmospora vasinfecta in a renal graft recipient. Transpl Proc 1993; 25: 2292.
- Chandenier J, Hayette MP, De Biel/re C, et al. Tumefaction de la jambe a Neocosmospora vasinfecta chez un transplant& renal. J Mycol Méd 1993; 3: 165–168.
- Dromer F, Improvisi L, Dupont B, et al. Oral transmission of Candida albicans between partners in HIV-infected couples could contribute to dissimination of fluconazole-resistant iso-lates. AIDS 1997; 11: 1095–1101.
- Cannon PF, Hawksworth DL. A revision of the genus Neocosmospora (Hypocreales). Trans Br Mycol Soc 1982; 82: 673–688.
- Guarro J, Gene J. Opportunistic fusarial infections in humans. Eur J Clin Microbial Infect Dis 1995; 14: 741–754.
- Nuovo MA, Simmonds JE, Chacho MS, McKitrick JC. Fusar-ium solani osteomyelitis with probable nosocomial spread. Am J Clin Path 1988; 90: 738–741.
- Warnock DW, Dupont B, Kauffman CA, Sirisanthanas T. Imported mycoses in Europe. Med Mycol 1998; 36 \((Suppl. 1)): 87–94.
- Fincher RME, Fisher JF, Lovell RD, et al. Infection due to the fungus Acremonium (Cephalosporium). Medicine 1991; 70: 398–409.
- McGinnis MR, Pasarell L, Sutton DA, et al. In vitro evaluation of voriconazole against some clinically important fungi. Antimi-crob Agents Chemother 1997; 41: 1832–1834.
- Espinel-Ingroff A. In vitro activity of the new triazole voricona-zole (UK-109,496) against opportunistic filamentous and di-morphic fungi and common and emerging yeast pathogens. J Clin Microbial 1998; 36: 198–202.
- Bennett JE. Antimicrobial agents. Antifungal agents. In: Good-man S, Gilman A eds. The Pharmacological Basis of Therapeu-tics, 8th edn. Pergamon Press Inc., 1990: 1165–1181.